Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ongoing therapeutic trials and outcome measures for Duchenne muscular dystrophy

17 Jun 2013

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiomyopathy and Myosin Studies
Share to Muscle Physiology and Disorders
Share to Tissue Engineering and Regenerative Medicine

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 23775131
DOI: 10.1007/s00018-013-1396-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ongoing therapeutic trials and outcome measures for Duchenne muscular dystrophyPMID 23775131Read ↗

Evolving Therapeutic Options for the Treatment of Duchenne Muscular DystrophySemantic proximity Read ↗

Therapeutic Approaches for Duchenne Muscular Dystrophy: Old and NewSemantic proximity Read ↗

Muscular dystrophy: new challenges and review of the current clinical trials.Semantic proximity Read ↗

[Clinical practice guidelines for Duchenne muscular dystrophy].Semantic proximity Read ↗

Molecular pathophysiology and targeted therapeutics for muscular dystrophySemantic proximity Read ↗

Consensus recommendations and considerations for the delivery and monitoring of gene therapy in patients with Duchenne muscular dystrophySemantic proximity Read ↗

An Overview of Recent Therapeutics Advances for Duchenne Muscular Dystrophy.Semantic proximity Read ↗

Drug development progress in duchenne muscular dystrophySemantic proximity Read ↗

Towards a Cure: Emerging Therapeutic Advances for DMD, LGMD, and GNEM- Insights from Pre-Clinical and Clinical ResearchSemantic proximity Read ↗

New and emerging pharmacotherapy for duchenne muscular dystrophy: a focus on synthetic therapeutics.Semantic proximity Read ↗

Advances in Duchenne muscular dystrophy gene therapySemantic proximity Read ↗

An update on Becker muscular dystrophy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.